Recommended Non-Sedating Second-Generation H1 Antihistamines for Allergic Symptoms
For allergic symptoms, fexofenadine, loratadine, and desloratadine are the preferred second-generation antihistamines because they do not cause sedation at recommended doses, while cetirizine may cause mild sedation and should be used with caution in patients requiring optimal alertness 1.
Sedation Profile Hierarchy
The second-generation antihistamines differ significantly in their sedative properties 1:
Non-sedating at recommended doses:
- Fexofenadine (no sedation even at higher than FDA-approved doses)
- Loratadine
- Desloratadine
May cause sedation at recommended doses:
- Cetirizine (13.7% drowsiness vs 6.3% placebo in patients ≥12 years)
- Intranasal azelastine (11.5% somnolence)
Critical distinction: Among all second-generation agents, no single antihistamine has been conclusively found to achieve superior overall response rates 1. The primary differentiator is the side effect profile, particularly sedation, rather than efficacy 2.
Dosing by Age Group
Adults and Adolescents ≥12 Years
Standard dosing:
- Fexofenadine: 60 mg twice daily or 180 mg once daily
- Loratadine: 10 mg once daily
- Desloratadine: 5 mg once daily
- Cetirizine: 10 mg once daily (use with caution due to sedation risk)
Dose escalation: If symptoms persist after 2-4 weeks, up-dosing to four times the standard dose is recommended and safe 2, 3. Administer as two tablets twice daily for better convenience 2.
Children 6-11 Years
- Loratadine: 10 mg once daily
- Desloratadine: 2.5 mg once daily
- Cetirizine: 5-10 mg once daily (age-dependent)
Important caveat: Patients with low body mass receiving standard age-based dosing may reach elevated mg/kg levels, potentially causing drowsiness and performance impairment 1.
Children 2-5 Years
- Loratadine: 5 mg once daily
- Desloratadine: 1.25 mg once daily
- Cetirizine: 2.5-5 mg once daily
Second-generation antihistamines are preferable to first-generation agents in children due to better safety profile, minimal cognitive and antimuscarinic side effects, and longer duration of action 4.
Special Populations
Elderly Patients
Avoid first-generation antihistamines entirely 1, 5. Older adults are more sensitive to psychomotor impairment, at increased risk for falls leading to fractures and subdural hematomas, and more susceptible to adverse anticholinergic effects (particularly with comorbid conditions like increased intraocular pressure, benign prostatic hypertrophy, or preexisting cognitive impairment) 1.
Preferred agents:
- Fexofenadine (first choice - no sedation)
- Loratadine
- Desloratadine
Avoid or use extreme caution with:
- Cetirizine (dose-dependent sedation)
- Mizolastine (cardiac repolarization effects)
- Rupatadine and ebastine (especially in patients with arrhythmias) 5
Dose adjustments: May need reduction in hepatic dysfunction or renal insufficiency 5.
Pregnant Patients
Evidence is limited, but second-generation antihistamines are generally preferred over first-generation agents when treatment is necessary. Use appropriate caution and the lowest effective dose 3.
Breastfeeding Patients
Second-generation antihistamines are generally considered safer than first-generation agents, though caution is advised. Fexofenadine, loratadine, and desloratadine are reasonable options 3.
Patients with Renal or Hepatic Impairment
Dose adjustment required for some agents. Fexofenadine may be preferred as it has minimal hepatic metabolism 3.
Critical Contraindications to First-Generation Antihistamines
Never use first-generation antihistamines in patients with 1, 5:
- Narrow-angle glaucoma
- Benign prostatic hypertrophy
- Cognitive impairment or dementia risk
- Occupations requiring alertness (driving, operating machinery)
- Concurrent use of other CNS-active substances (alcohol, sedatives, antidepressants)
- Elderly patients (American Geriatrics Society recommendation)
Rationale: First-generation antihistamines cause significant daytime drowsiness, decreased alertness, and performance impairment even when dosed only at bedtime due to prolonged plasma half-lives 1. They are associated with 1.5 times increased risk of fatal automobile accidents 1 and impaired work performance 1.
Common Pitfalls to Avoid
Do NOT combine AM second-generation with PM first-generation antihistamine - this strategy does not avoid daytime impairment and is not recommended 1.
Do NOT combine different second-generation antihistamines simultaneously - this is not superior to high-dose monotherapy and adds unknown interactions and side effects 2.
Do NOT exceed four times the standard dose - higher doses are not recommended 2.
Counsel patients on cetirizine sedation risk - even though it may not cause performance impairment, 13.7% experience drowsiness 1.
Consider total anticholinergic burden - particularly in elderly patients on multiple medications 5.
Treatment Algorithm
Step 1: Start with standard-dose fexofenadine, loratadine, or desloratadine (taken regularly, not on-demand) 2
Step 2: If inadequate response after 2-4 weeks, increase to up to four times standard dose 2, 3
Step 3: If symptoms persist beyond 4 weeks at maximum dose, add alternative therapy (not another antihistamine) 2
For elderly or high-risk patients: Start with fexofenadine as first choice due to complete absence of sedation 1.